首页> 外文期刊>International Medical Case Reports Journal >Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microa- neurysm photocoagulation on diabetic macular edema
【24h】

Effects of sub-Tenon's capsule triamcinolone acetonide injection combined with microa- neurysm photocoagulation on diabetic macular edema

机译:特农膜下注射曲安奈德联合微动脉瘤光凝治疗糖尿病性黄斑水肿的效果

获取原文
           

摘要

Purpose: To compare the effects of sub-Tenon's capsule triamcinolone acetonide (STTA) injection to that of STTA injection combined with microaneurysm photocoagulation (MAPC; STTA + MAPC) on eyes with diabetic macular edema (DME). Patients and methods: The medical records of 138 eyes of 138 patients with DME treated by either STTA or STTA + MAPC were reviewed. The degree of DME was determined by the optical coherence tomographic features: patients with serous retinal detachment (SRD+; 38 eyes) and patients without SRD (non-SRD; 100 eyes). The central macular thickness (CMT) and the best-corrected visual acuity (BCVA) were measured periodically for 6 months after the treatments. Results: The BCVA was significantly improved in the non-SRD group after STTA + MAPC. The CMT was significantly improved in all groups and improved considerably more in the non-SRD group than in the SRD+ group after STTA + MAPC. Conclusion: Our findings indicate that MAPC has an additive effect in the non-SRD type.
机译:目的:比较特农膜下注射丙酮曲安奈德(STTA)与STTA注射结合微动脉瘤光凝(MAPC; STTA + MAPC)对糖尿病性黄斑水肿(DME)的影响。患者和方法:回顾了STTA或STTA + MAPC治疗的138例DME患者的138眼的医疗记录。 DME的程度由光学相干断层扫描特征确定:患有浆液性视网膜脱离的患者(SRD +; 38眼)和没有SRD的患者(非SRD; 100眼)。治疗后6个月定期测量中央黄斑厚度(CMT)和最佳矫正视力(BCVA)。结果:STTA + MAPC后,非SRD组的BCVA明显改善。 STTA + MAPC后,所有组的CMT均显着改善,非SRD组的CMT显着高于SRD +组。结论:我们的发现表明,MAPC在非SRD类型中具有加和作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号